☤ Bryce Chaney, MBA’s Post

𝐏𝐟𝐢𝐳𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐞𝐬 𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐟𝐨𝐫 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 ✅ Today, The U.S. FDA has approved Pfizer's BEQVEZ™, a one-time gene therapy for adults with hemophilia B. 👉 This therapy has shown significant reduction in bleeds post-treatment compared to standard care, potentially eliminating the need for regular infusions of factor IX (FIX). Hemophilia B, a rare genetic disorder, causes frequent and prolonged bleeding due to a deficiency in FIX. BEQVEZ offers a promising alternative, reducing both medical and treatment burden over the long term. With over 38,000 people worldwide living with haemophilia B. Read more... #genetherapy #cellandgenetherapy #biotech #regenerativemedicine

🚨 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 166+ global cell therapy companies below focused on oncology and categorised by the following areas; - NK cells - T cells - Other 📈 It's exciting to witness the resilience and expansion of NK cell-focused companies and the emergence of innovative start-ups in the 'Other' category. This convergence creates a fascinating overlap on the Venn diagram of cell therapy innovation. Huge credit to 𝐒𝐚𝐦𝐢 𝐂𝐨𝐫𝐰𝐢𝐧, 𝐏𝐡.𝐃. + 𝐖𝐢𝐥𝐥𝐢𝐚𝐦 𝐁𝐥𝐚𝐢𝐫 for another fantastic piece as well as company reports. #celltherapy #oncology #biotech #CGTweekly